Ziprasidone in adolescents with schizophrenia: results from a placebo-controlled efficacy and long-term open-extension study.
about
Do Atypical Antipsychotics Have Antisuicidal Effects? A Hypothesis-Generating OverviewAtypical antipsychotics in the treatment of early-onset schizophreniaQuetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trialSafety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with Schizophrenia.Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth.Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose TrialDevelopment of novel therapy of schizophrenia in children and adolescents.QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.Evaluation of the pharmacokinetics, safety and clinical efficacy of ziprasidone for the treatment of schizophrenia and bipolar disorder.Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions.Efficacy and Safety of Lurasidone in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study.Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders.
P2860
Q28077687-DFBA93D6-08D9-4A6D-9151-A9EA02CFA80EQ28083361-49FEFC91-6C15-4AEE-8CAA-8594E886CE0FQ34486230-C3582C18-2F7C-41FB-A72E-02F210AB9F6DQ35816572-AAB29B23-97BE-46BE-B953-B8A70B609B8EQ37061277-4A33F804-84D1-4E58-82F4-AB37BC50CC5EQ37246368-5EA463DA-3346-4B11-90AD-B64B6D8080B3Q38223714-1FC27B12-BA35-4F2B-A3A7-7C8F0BCCB999Q38244346-0803F9A6-2564-4C7D-80AD-90B2524D53FFQ38284625-525F6C5C-69D8-4BC2-A0B8-78A92F475D56Q38838664-20413556-2E4A-452F-ACFD-179CB99468FDQ41495591-0D6ED882-6BE1-4DAA-93FE-0E8999E2D055Q55074589-ECCB6586-F7BE-49F4-99F7-180BD8254DF7
P2860
Ziprasidone in adolescents with schizophrenia: results from a placebo-controlled efficacy and long-term open-extension study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ziprasidone in adolescents wit ...... ong-term open-extension study.
@en
Ziprasidone in adolescents wit ...... ong-term open-extension study.
@nl
type
label
Ziprasidone in adolescents wit ...... ong-term open-extension study.
@en
Ziprasidone in adolescents wit ...... ong-term open-extension study.
@nl
prefLabel
Ziprasidone in adolescents wit ...... ong-term open-extension study.
@en
Ziprasidone in adolescents wit ...... ong-term open-extension study.
@nl
P2093
P2860
P921
P356
P1476
Ziprasidone in adolescents wit ...... ong-term open-extension study.
@en
P2093
Balarama K Gundapaneni
Douglas G Vanderburg
Elizabeth Pappadopulos
Idil Cavuş
Jeffrey H Schwartz
Melissa P DelBello
Robert L Findling
P2860
P304
P356
10.1089/CAP.2012.0068
P577
2013-10-10T00:00:00Z